Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis.
<h4>Background</h4>In Uganda, isoniazid plus ethambutol is used for 6 months (6HE) during the continuation treatment phase of new tuberculosis (TB) cases. However, the World Health Organization (WHO) recommends using isoniazid plus rifampicin for 4 months (4HR) instead of 6HE. We compare...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Public Library of Science (PLoS)
2012
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/c758d8673f4d471f8d969bb25ba89a2b |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|